Tudor Investment Corp’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08M | Buy |
114,964
+46,687
| +68% | +$438K | ﹤0.01% | 1081 |
|
|
2025
Q1 | $485K | Buy |
+68,277
| New | +$485K | ﹤0.01% | 1222 |
|
|
2024
Q4 | – | Sell |
-24,803
| Closed | -$510K | – | 1932 |
|
|
2024
Q3 | $510K | Sell |
24,803
-36,980
| -60% | -$760K | ﹤0.01% | 1228 |
|
|
2024
Q2 | $1.38M | Buy |
61,783
+14,308
| +30% | +$320K | 0.01% | 866 |
|
|
2024
Q1 | $1.31M | Buy |
+47,475
| New | +$1.31M | 0.01% | 805 |
|
|
2023
Q4 | – | Sell |
-7,638
| Closed | -$242K | – | 1795 |
|
|
2023
Q3 | $242K | Buy |
+7,638
| New | +$242K | ﹤0.01% | 1289 |
|
|
2023
Q1 | – | Sell |
-44,902
| Closed | -$1.57M | – | 1861 |
|
|
2022
Q4 | $1.57M | Buy |
44,902
+13,817
| +44% | +$482K | 0.03% | 645 |
|
|
2022
Q3 | $1.74M | Buy |
+31,085
| New | +$1.74M | 0.04% | 569 |
|
|
2022
Q2 | – | Sell |
-19,273
| Closed | -$1.4M | – | 1841 |
|
|
2022
Q1 | $1.4M | Buy |
+19,273
| New | +$1.4M | 0.03% | 695 |
|
|
2021
Q4 | – | Sell |
-12,109
| Closed | -$1.62M | – | 1921 |
|
|
2021
Q3 | $1.62M | Buy |
12,109
+4,654
| +62% | +$624K | 0.03% | 673 |
|
|
2021
Q2 | $1.21M | Buy |
+7,455
| New | +$1.21M | 0.02% | 742 |
|